FDA appoints new CEO


Effective 4 August, Kate Sharp has been appointed the new chief executive officer (CEO) of the Factors & Discounters Association (FDA), the body that serves the interests of the Ј100 billion industry of factors, discounters and asset-based lenders in the UK and Ireland. The first woman to be appointed as CEO, Kate takes over from Robin Clarke.

Kate joins the FDA from Highams Business Solutions, with over 14 years of industry experience. Kate was the factoring business manager at Highams who are a leading provider of factoring and asset based lending software to factoring companies worldwide.



All news and features older than 7 days are subscription only. This article is from the archive. Archived articles could only be accessed with the subscription. If you are a subscriber please log in, alternatively you need to purchase a subscription to view the full content for this page.